Know Labs unveils non-invasive CGM
By HME News Staff
Updated 9:56 AM CST, Thu February 29, 2024
SEATTLE – Know Labs, an emerging developer of non-invasive medical diagnostic technology, has unveiled KnowU, a wearable non-invasive continuous glucose monitor (CGM), the result of an accelerated development process over the last eight months. The KnowU incorporates the sensor that the company plans to submit to the U.S. Food and Drug Administration for clearance. “The prevalence of diabetes is growing globally at an alarming rate,” said Ron Erickson, CEO and chairman. “Millions of people face significant barriers in accessing the technology and treatment they need to effectively manage their diabetes. Know Labs is committed to delivering an accessible, affordable, and accurate solution that improves the current standard of care and enhances the quality of life for those living with diabetes.” KnowU can be worn with an adhesive, allowing the user to clip the sensor on and off, or on the wrist or forearm with a strap. The device includes on-board computing power and built-in machine learning capabilities.
Comments